Ginkgo Bioworks Acquires Microbial Innovation Firm AgBiome's Platform Assets
(RTTNews) - Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced Thursday the acquisition of microbial innovation firm AgBiome, Inc.'s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome's development pipeline.
These assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022, and will expand Ginkgo's proprietary unified metagenomics database.
Combined, this creates one of the deepest and most advanced ag biological discovery and development platforms as well as a rich resource for the development of AI models for biological R&D.
Also included in the acquisition is a robust product concept pipeline including a dozen product candidates with greenhouse or field validation. These validated assets create a rich foundation for future partnered programs, as well as a diverse resource of metagenomic data for genomic mining and AI model training.
Imagindairy And Ginkgo Bioworks Partner To Develop Animal-Free Non-Whey Dairy Proteins
Ginkgo Bioworks Expects To Meet FY23 Revenue Guidance Ranges
Agrivalle Partners Ginkgo Bioworks To Advance Its Biological Products
NAMUH, Ginkgo Bioworks Ink Partnership To Develop Functional Oligosaccharides
Ginkgo Bioworks Acquires Biotechnology Company Circularis For Undisclosed Terms
Ginkgo Bioworks To Acquire Zymergen In All-stock Deal
UK Stocks Move In Tight Range; FTSE Down Slightly
